ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $30,050 | +114.0% | 10,050 | -0.5% | 0.00% | – |
| Q2 2023 | $14,042 | -6.4% | 10,102 | +336.9% | 0.00% | – |
| Q2 2022 | $15,000 | +1400.0% | 2,312 | +1156.5% | 0.00% | – |
| Q1 2022 | $1,000 | – | 184 | +84.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 100 | -81.8% | 0.00% | – |
| Q3 2021 | $7,000 | +75.0% | 550 | +227.4% | 0.00% | – |
| Q2 2021 | $4,000 | 0.0% | 168 | +5.7% | 0.00% | – |
| Q1 2021 | $4,000 | -66.7% | 159 | -64.7% | 0.00% | – |
| Q4 2020 | $12,000 | -25.0% | 450 | 0.0% | 0.00% | – |
| Q3 2020 | $16,000 | -42.9% | 450 | -18.2% | 0.00% | – |
| Q2 2020 | $28,000 | – | 550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 1,275,000 | $45,020,000 | 9.84% |
| Aviva Holdings Ltd. | 340,100 | $12,009,000 | 5.60% |
| Aisling Capital LLC | 837,125 | $29,559,000 | 5.38% |
| RA Capital Management | 704,701 | $24,883,000 | 3.05% |
| Rhenman & Partners Asset Management AB | 543,347 | $19,186,000 | 3.04% |
| BB BIOTECH AG | 1,408,542 | $49,736,000 | 1.63% |
| Antipodean Advisors LLC | 91,000 | $3,213,000 | 1.57% |
| Iguana Healthcare Management, LLC | 75,000 | $2,648,000 | 1.31% |
| Crawford Lake Capital Management, LLC | 93,551 | $3,303,000 | 1.31% |
| FT Options LLC | 22,834 | $806,000 | 1.06% |